TGFB1 and neoplasm: Tumor-associated B cells can promote tumor inflammation [58], for instance through B cell receptor stimulation by melanoma derived antigens [59], and also inhibit T cell-dependent therapy responses through the release of IL-10 and TGF-β [60].